Literature DB >> 9660926

Tumor suppressor p16INK4A: determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4.

I J Byeon1, J Li, K Ericson, T L Selby, A Tevelev, H J Kim, P O'Maille, M D Tsai.   

Abstract

The solution structure of the tumor suppressor p16INK4A has been determined by NMR, and important recognition regions of both cdk4 and p16INK4A have been identified. The tertiary structure of p16INK4A contains four helix-turn-helix motifs linked by three loops. Twelve tumorigenic mutants of p16INK4A have been constructed and analyzed for their structure and activity, and new mutants have been designed rationally. A fragment of 58 residues at the N terminus of cdk4 important for p16INK4A binding has been identified. The importance of this region was further verified by mutational analysis of cdk4. These results and docking experiments have been used to assess possible modes of binding between p16INK4A and cdk4.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9660926     DOI: 10.1016/s1097-2765(00)80042-8

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  37 in total

Review 1.  Utilizing NMR to study the structure of growth-inhibitory proteins.

Authors:  Francesca Marassi
Journal:  Methods Mol Biol       Date:  2003

2.  Designed to be stable: crystal structure of a consensus ankyrin repeat protein.

Authors:  Andreas Kohl; H Kaspar Binz; Patrik Forrer; Michael T Stumpp; Andreas Plückthun; Markus G Grütter
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-03       Impact factor: 11.205

3.  Ankyrin repeat and SOCS box 3 (ASB3) mediates ubiquitination and degradation of tumor necrosis factor receptor II.

Authors:  Alicia S Chung; Ying-Jie Guan; Zheng-Long Yuan; Jorge E Albina; Y Eugene Chin
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

4.  High prevalence of germline CDKN2A mutations in Slovenian cutaneous malignant melanoma families.

Authors:  Marko Hocevar; Magdalena Avbelj; Barbara Perić; Janez Zgajnar; Nikola Besić; Tadej Battelino
Journal:  Croat Med J       Date:  2006-12       Impact factor: 1.351

5.  Phospho-SXXE/D motif mediated TNF receptor 1-TRADD death domain complex formation for T cell activation and migration.

Authors:  Ying-Jie Guan; Zhe Zhang; Chen Yu; Li Ma; Weiling Hu; Li Xu; Jin-Song Gao; Chun-Shiang Chung; Lijuan Wang; Zhong-Fa Yang; Loren D Fast; Alicia S Chung; Minsoo Kim; Alfred Ayala; Shougang Zhuang; Shusen Zheng; Y Eugene Chin
Journal:  J Immunol       Date:  2011-07-01       Impact factor: 5.422

Review 6.  Selectivity and potency of cyclin-dependent kinase inhibitors.

Authors:  Jayalakshmi Sridhar; Nagaraju Akula; Nagarajan Pattabiraman
Journal:  AAPS J       Date:  2006-03-24       Impact factor: 4.009

7.  Assessment of functional effects of unclassified genetic variants.

Authors:  Fergus J Couch; Lene Juel Rasmussen; Robert Hofstra; Alvaro N A Monteiro; Marc S Greenblatt; Niels de Wind
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

8.  Mutational analysis of CDKN2A gene in a group of 390 larynx cancer patients.

Authors:  Katarzyna Kiwerska; Małgorzata Rydzanicz; Andrzej Kram; Martyna Pastok; Agata Antkowiak; Wenancjusz Domagała; Krzysztof Szyfter
Journal:  Mol Biol Rep       Date:  2009-08-19       Impact factor: 2.316

9.  Simulation of different truncated p16(INK4a) forms and in silico study of interaction with Cdk4.

Authors:  Najmeh Fahham; Mohammad Hossein Ghahremani; Soroush Sardari; Behrouz Vaziri; Seyed Nasser Ostad
Journal:  Cancer Inform       Date:  2008-12-03

10.  Disruption of chromosome 11 in canine fibrosarcomas highlights an unusual variability of CDKN2B in dogs.

Authors:  Jesús Aguirre-Hernández; Bruce S Milne; Chris Queen; Patricia C M O'Brien; Tess Hoather; Sean Haugland; Malcolm A Ferguson-Smith; Jane M Dobson; David R Sargan
Journal:  BMC Vet Res       Date:  2009-07-31       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.